Driehaus Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Driehaus Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-617,559	Closed	-$7.36M	–	685
2014 Q3	$7.36M	Buy	617,559 +255,864	+71%	+$1.75M	0.28%	88
2014 Q2	$2.04M	Buy	+361,695	New	+$1.67M	0.07%	344
2014 Q1	–	Sell	-1,095,122	Closed	-$3.68M	–	642
2013 Q4	$3.68M	Sell	1,095,122 -351,717	-24%	-$1.45M	0.13%	213
2013 Q3	$6.12M	Buy	1,446,839 +928,995	+179%	+$4.4M	0.24%	137
2013 Q2	$2.38M	Buy	+517,844	New	+$1.78M	0.1%	238

Other funds holding AVNR

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Driehaus Capital Management's AVNR Position: Q4 2014 in Review

Driehaus Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 617,559 shares — an estimated $7.36M sold.

Driehaus Capital Management first reported a position in AVNR in Q2 2013 and held it in 5 quarters. The position peaked at $7.36M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

Driehaus Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
Driehaus Capital Management sold 617,559 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $7.36M.
Driehaus Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 5 quarters.
Driehaus Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $7.36M in Q3 2014.
166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Driehaus Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.